MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia. - Wikidata - awgldk - TriplyDB

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia.

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q46755084

about

Clinical implications of the molecular genetics of chronic lymphocytic leukemia Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis Mga is essential for the survival of pluripotent cells during peri-implantation development.Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations An overview of MYC and its interactome.Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications.Mutations driving CLL and their evolution in progression and relapse.MYC addiction in chronic lymphocytic leukemia.Treatment of Richter's Syndrome.Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.Mga Modulates Bmpr1a Activity by Antagonizing Bs69 in Zebrafish

P2860

Q26830955-E1CCA7A1-CAB8-4456-BCCB-638AB099E5A3 Q26853567-41FE49E3-CEC2-4EC5-956B-7E0E9635BE72 Q34985223-6B3F31C7-DEC2-4930-A7F4-72F5ADB327A4 Q36622188-D742A8F0-933B-4E9B-988A-1CF1CFA0451A Q37406278-86FEF090-A3F9-4539-A759-C41301327386 Q37697850-4B149BA4-E66A-4937-988F-F305ED8602AB Q38286344-0F115438-B7EB-4981-9749-EDA5EF5D7D64 Q39714436-41D13CFF-9CA4-4333-8345-E158C5A84C3F Q44879882-350F6DCE-5EB5-4FD2-8B79-15A3D362CA7D Q49843910-26F9F225-69CE-4D74-83BD-D8FDF50CB1D8 Q52723228-03DCC882-97E4-4CF7-B27A-2C0DEA945485 Q57490038-41D01E71-BF91-4EBC-81F8-7EEC5E21BCEB

P2860

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q46755084

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

MGA, a suppressor of MYC, is r ...... chronic lymphocytic leukemia.

@en

MGA, a suppressor of MYC, is r ...... chronic lymphocytic leukemia.

@nl

type

label

MGA, a suppressor of MYC, is r ...... chronic lymphocytic leukemia.

@en

MGA, a suppressor of MYC, is r ...... chronic lymphocytic leukemia.

@nl

prefLabel

MGA, a suppressor of MYC, is r ...... chronic lymphocytic leukemia.

@en

MGA, a suppressor of MYC, is r ...... chronic lymphocytic leukemia.

@nl

P1433

Q46755084-81F6351E-7009-4FF0-AC78-F5C39895E171

P1476

Q46755084-6C5ED1A1-6C76-4748-A2AF-9CC21634E2D9

P2093

Q46755084-1C36C2FD-58AF-45B1-8964-90ACA6B07586

Q46755084-377D7303-9F77-460B-919F-EE7B3E7EC759

Q46755084-390BA52B-9FB6-4BB0-AC3D-EA6D2709CF24

Q46755084-573BDE15-56FF-447D-AD8D-4CDC638E4ACB

Q46755084-5D4E9ECD-D31A-4E71-B46E-9DD71A88144F

Q46755084-92F201D2-F27B-4064-8A6B-8F51F47E011B

Q46755084-C20FC22E-D85F-4778-A443-41A04DB6A530

Q46755084-CB734B76-AFED-4A18-83AD-D3E412707AF4

Q46755084-CC5BA3DF-6FF0-4182-9289-6A91139484D2

Q46755084-F34A93EA-6C03-48DD-BF82-64F4C1C6DDF7

P2860

Q46755084-1C049891-EADB-4AF9-A087-986431987782

Q46755084-38A53D60-595A-43FC-BDAF-9A740B72DFBF

Q46755084-4A43ECAB-3B9C-48F2-A56F-4F0652436F6B

Q46755084-592300AE-9A30-41D2-9945-C1D437CB6E3C

Q46755084-597C0E8E-9274-45E9-AF4B-0A8B70DFF881

Q46755084-9C1E1802-3E14-43F9-BA7C-D2F04988190E

Q46755084-A327E263-4D45-4D2C-A188-6C0A0C76D749

Q46755084-A4779995-DC48-4552-9965-214CBB639883

Q46755084-BFB6B7A8-2427-4DEF-A590-B55CAB9DB3E5

Q46755084-CDF4A1F2-D102-4B9E-89D2-F10CD20CE112

P304

Q46755084-9D48774E-E4FA-4D6D-9DE6-0B37DE7EA19B

P31

Q46755084-C949AB60-ECD6-4BEB-B3F6-7AB12DAA8B16

P356

Q46755084-05F3CE7C-1A03-4700-B09B-CAB48101FE45

P433

Q46755084-4ABC68F8-649E-487F-BF4D-70F6D5A9EF4F

P478

Q46755084-A67F7B13-841D-4AB6-9BC9-F72D3DDA6600

P50

Q46755084-367D886C-B955-4B61-B8AC-480F9AE86E5D

Q46755084-47E0E20E-DE5D-4551-AD0A-247CE9151A28

Q46755084-5D7ADDFB-DA99-4743-8C69-5B1A3E4D9EB9

Q46755084-8C72AF19-6D3D-4520-A9EA-A3B4AD06236F

Q46755084-CF931C0C-4642-47A2-BC94-9CB7741602E5

Q46755084-DEBE7285-659E-48A2-911A-8507D4DD0831

Q46755084-E0F2F036-91DA-41DB-A779-C64B224563A8

Q46755084-E55F3E47-B4A5-43EF-A32C-23604CEDA2D4

Q46755084-EDF4FCBD-0DD9-4127-A219-9C65047714EB

P577

Q46755084-AF866485-D525-4FF4-B2E2-052A7CB50311

P698

Q46755084-927D7319-0AD8-4248-864A-F749EEB52F6C

P921

Q46755084-2C3C0290-63FB-40C3-9B2C-57BE7551EB65

Q46755084-632AA418-F59F-4B61-8F5E-1F8F4B65EAAF

P356

10428194.2012.723706

P1433

Leukemia & Lymphoma

P1476

MGA, a suppressor of MYC, is r ...... chronic lymphocytic leukemia.

@en

P2093

Alessio Bruscaggin

http://www.w3.org/2001/XMLSchema#string

Carmela Ciardullo

http://www.w3.org/2001/XMLSchema#string

Davide Rossi

http://www.w3.org/2001/XMLSchema#string

Luca Laurenti

http://www.w3.org/2001/XMLSchema#string

Mariangela Greco

http://www.w3.org/2001/XMLSchema#string

Michaela Cerri

http://www.w3.org/2001/XMLSchema#string

Rosella Famà

http://www.w3.org/2001/XMLSchema#string

Sara Monti

http://www.w3.org/2001/XMLSchema#string

Silvia Rasi

http://www.w3.org/2001/XMLSchema#string

Stefania Cresta

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia.

Risk categories and refractory CLL in the era of chemoimmunotherapy.

Predictive markers and driving factors behind Richter syndrome development.

Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation.

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

P304

1087-1090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2012.723706

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Gianluca Gaidano

Francesco Forconi

Roberto Marasca

Francesco Bertoni

Maurizio Martini

Luigi Maria Larocca

Lorenzo De Paoli

P577

2012-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23039309

http://www.w3.org/2001/XMLSchema#string

P921